A detailed history of Synovus Financial Corp transactions in Novartis Ag stock. As of the latest transaction made, Synovus Financial Corp holds 13,429 shares of NVS stock, worth $1.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
13,429
Previous 19,404 30.79%
Holding current value
$1.48 Million
Previous $1.88 Million 23.83%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $553,105 - $641,535
-5,975 Reduced 30.79%
13,429 $1.43 Million
Q1 2024

May 14, 2024

BUY
$95.27 - $108.47 $3,143 - $3,579
33 Added 0.17%
19,404 $1.88 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $4,357 - $4,835
46 Added 0.24%
19,371 $1.97 Million
Q2 2023

Aug 08, 2023

SELL
$92.52 - $104.91 $80,399 - $91,166
-869 Reduced 4.3%
19,325 $1.95 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $339,247 - $393,421
-4,239 Reduced 17.35%
20,194 $1.86 Million
Q4 2022

Feb 06, 2023

BUY
$75.55 - $92.52 $107,809 - $132,026
1,427 Added 6.2%
24,433 $2.22 Million
Q3 2022

Oct 27, 2022

BUY
$74.61 - $87.26 $80,429 - $94,066
1,078 Added 4.92%
23,006 $1.75 Million
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $12,722 - $14,812
158 Added 0.73%
21,928 $1.85 Million
Q1 2022

May 12, 2022

SELL
$80.11 - $90.62 $69,695 - $78,839
-870 Reduced 3.84%
21,770 $1.91 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $260,937 - $288,537
-3,274 Reduced 12.63%
22,640 $1.97 Million
Q3 2021

Nov 08, 2021

SELL
$81.78 - $95.14 $986,021 - $1.15 Million
-12,057 Reduced 31.75%
25,914 $2.12 Million
Q2 2021

Aug 11, 2021

BUY
$85.24 - $94.15 $33,925 - $37,471
398 Added 1.06%
37,971 $3.45 Million
Q1 2021

May 11, 2021

BUY
$83.5 - $98.47 $207,414 - $244,599
2,484 Added 7.08%
37,573 $3.21 Million
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $4,293 - $5,193
-55 Reduced 0.16%
35,089 $3.31 Million
Q3 2020

Nov 09, 2020

SELL
$82.14 - $91.0 $439,120 - $486,486
-5,346 Reduced 13.2%
35,144 $3.05 Million
Q2 2020

Aug 10, 2020

SELL
$80.93 - $91.1 $308,424 - $347,182
-3,811 Reduced 8.6%
40,490 $3.53 Million
Q1 2020

Apr 24, 2020

BUY
$70.67 - $99.01 $138,583 - $194,158
1,961 Added 4.63%
44,301 $3.65 Million
Q4 2019

Feb 06, 2020

BUY
$84.35 - $95.37 $25,305 - $28,611
300 Added 0.71%
42,340 $4.01 Million
Q3 2019

Nov 01, 2019

BUY
$85.54 - $94.26 $37,380 - $41,191
437 Added 1.05%
42,040 $3.65 Million
Q2 2019

Aug 08, 2019

SELL
$75.4 - $92.8 $32,572 - $40,089
-432 Reduced 1.03%
41,603 $3.79 Million
Q1 2019

May 09, 2019

SELL
$75.32 - $86.15 $241,852 - $276,627
-3,211 Reduced 7.1%
42,035 $4.05 Million
Q4 2018

Feb 07, 2019

BUY
$73.66 - $82.02 $28,580 - $31,823
388 Added 0.86%
45,246 $3.89 Million
Q3 2018

Nov 01, 2018

BUY
$66.94 - $77.43 $18,944 - $21,912
283 Added 0.63%
44,858 $3.87 Million
Q2 2018

Aug 01, 2018

BUY
$64.91 - $73.36 $57,964 - $65,510
893 Added 2.04%
44,575 $3.36 Million
Q1 2018

May 07, 2018

BUY
$70.39 - $84.15 $378,487 - $452,474
5,377 Added 14.04%
43,682 $3.53 Million
Q4 2017

Feb 09, 2018

SELL
$72.33 - $77.64 $148,782 - $159,705
-2,057 Reduced 5.1%
38,305 $3.22 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $2.99 Million - $3.12 Million
40,362
40,362 $3.47 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.